Publications by authors named "Michael Vogelbaum"

Claim this Profile
C
Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trial.
Martin J van den Bent, Santoesha A Ghisai, Wolfgang Wick, Marc Sanson, Alba Ariela Brandes, Michael A Vogelbaum

Lancet Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comprehensive framework for glioma surgery by the PIONEER Consortium and RANO resect group, part 1: intraoperative recommendations for mapping, monitoring, and decision making.
Jasper K W Gerritsen, Philipp Karschnia, Lorenzo Bello, Shawn Hervey-Jumper, Jacob S Young, Michael A Vogelbaum

Lancet Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comprehensive framework for glioma surgery by the PIONEER Consortium and RANO resect group, part 2: perioperative recommendations for neurological, language, functional, and quality-of-life assessment.
Jasper K W Gerritsen, Philipp Karschnia, Lorenzo Bello, Shawn Hervey-Jumper, Jacob S Young, Michael A Vogelbaum

Lancet Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group.
Philipp Karschnia, Jacob S Young, Maarten M J Wijnenga, Tommaso Sciortino, Nico Teske, Michael A Vogelbaum

Lancet Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a Pilot Trial of Infusion Rate Escalation During Convection Enhanced Delivery of Topotecan with a Multiport Catheter.
James K C Liu, Nam Tran, Cecily Piteo, Alisa Peinhardt, Michael A Vogelbaum

World Neurosurg· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response Assessment in Neuro-Oncology (RANO) 2009-2025: Broad scope and implementation-A progress report.
Martin J van den Bent, Michael A Vogelbaum, Tim Cloughesy, Norbert Galldiks, Nathalie L Albert

Neuro Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations of supramaximal resection with outcome in glioblastoma across age groups: a report of the RANO resect group.
Nico Teske, Antonio Dono, Jacob S Young, Stephanie T Juenger, Gilbert C Youssef, Michael A Vogelbaum

Neuro Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benchmarking the efficacy of salvage systemic therapies for recurrent meningioma: A RANO group systematic review and meta-analysis to guide clinical trial design.
Rupesh Kotecha, Eyub Y Akdemir, Tugce Kutuk, Can Ilgın, Manmeet S Ahluwalia, Michael A Vogelbaum

Neuro Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.
Farshad Nassiri, Vikas Patil, Leeor S Yefet, Olivia Singh, Jeff Liu, Michael A Vogelbaum

Nat Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update to the RANO working group and EANO recommendations for the clinical use of PET imaging in gliomas.
Norbert Galldiks, Philipp Lohmann, Mariam Aboian, Ramon F Barajas, William G Breen, Michael Vogelbaum

Lancet Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium.
Chetan Bettegowda, Houtan Noushmehr, Alessandra Affinito, Manmeet S Ahluwalia, Olaf Ansorge, Michael A Vogelbaum

Neuro Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RANO seizure working group-Tumor Related Epilepsy Assessment Tool (RANO-TREAT) to assess seizure control for glioma treatment trials and clinical practice.
Edward K Avila, Anne S Reiner, Terri S Armstrong, Ashley E Aaroe, Elizabeth M Cunningham, Michael A Vogelbaum

Neuro Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Use of Minor Response, Volumetric Assessment and Growth Rate Kinetics as Endpoints in Grade 1-3 Glioma Clinical Trials: a RANO perspective.
Martin J van den Bent, Timothy F Cloughesy, Benjamin M Ellingson, Joshua E Allen, Samuel C Blackman, Michael A Vogelbaum

Neuro Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional Reprogramming of Neutrophils within the Brain Tumor Microenvironment by Hypoxia-Driven Histone Lactylation.
Alessio Ugolini, Alessandra De Leo, Xiaoqing Yu, Fabio Scirocchi, Xiaoxian Liu, Michael A Vogelbaum

Cancer Discov· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Chromatin landscapes reveal developmentally encoded transcriptional states that define human glioblastoma.
Stephen C Mack, Irtisha Singh, Xiuxing Wang, Rachel Hirsch, Quilian Wu, Michael A Vogelbaum

J Exp Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a clinical risk model for postoperative outcome in newly diagnosed glioblastoma: A report of the RANO resect group.
Philipp Karschnia, Jacob S Young, Gilbert C Youssef, Antonio Dono, Levin Häni, Michael A Vogelbaum

Neuro Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of open and percutaneous instrumented fixation for the treatment of spinal metastases.
Arkady Bilenkin, Anna Barnes, Amanda Brisco, Junmin Whiting, Nam D Tran, Michael A Vogelbaum

Neurosurg Focus· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standard for PET imaging of brain metastases: version 1.0.
Antoine Verger, Nelleke Tolboom, Francesco Cicone, Susan M Chang, Julia Furtner, Michael A Vogelbaum

Eur J Nucl Med Mol Imaging· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous Immunoglobulin (IVIG) for Patients with Severe Neurotoxicity Associated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy.
Sepideh Mokhtari, Justin M Asquith, Syeda Saba Kareem, Christina A Bachmeier, Yolanda Pina, Michael A Vogelbaum

Int J Mol Sci· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidisciplinary management strategies for recurrent brain metastasis after prior radiotherapy: An overview.
Rupesh Kotecha, Alonso La Rosa, Paul D Brown, Michael A Vogelbaum, Pierina Navarria

Neuro Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply.
Benjamin M Ellingson, Francesco Sanvito, Whitney B Pope, Timothy F Cloughesy, Raymond Y Huang, Michael A Vogelbaum

AJNR Am J Neuroradiol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 1: review of current advancements.
Javier E Villanueva-Meyer, Spyridon Bakas, Pallavi Tiwari, Janine M Lupo, Evan Calabrese, Michael A Vogelbaum

Lancet Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 2: recommendations for standardisation, validation, and good clinical practice.
Spyridon Bakas, Philipp Vollmuth, Norbert Galldiks, Thomas C Booth, Hugo J W L Aerts, Michael Vogelbaum

Lancet Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A brave new framework for glioma drug development.
Kelly M Hotchkiss, Philipp Karschnia, Karisa C Schreck, Marjolein Geurts, Timothy F Cloughesy, Michael A Vogelbaum

Lancet Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma.
Santoesha A Ghisai, Levi van Hijfte, Wies R Vallentgoed, C Mircea S Tesileanu, Iris de Heer, Michael A Vogelbaum

Acta Neuropathol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis